Pathos
1 known investors
Pathos is an AI-enabled, clinical-stage biotech developing precision oncology therapies using a platform that combines multimodal patient data (genomics, transcriptomics, imaging, and longitudinal clinical outcomes) with AI agents to identify responsive patient populations and design clinical trials. It works with biopharma partners to advance clinical oncology programs.
AI & Machine LearningBiotechDigital Health
Investors · 1
Founder mafia
2 people who came through Pathos went on to found or lead other companies.
Frequently asked questions
- What does Pathos do?
- Pathos is an AI-enabled, clinical-stage biotech developing precision oncology therapies using a platform that combines multimodal patient data (genomics, transcriptomics, imaging, and longitudinal clinical outcomes) with AI agents to identify responsive patient populations and design clinical trials. It works with biopharma partners to advance clinical oncology programs.
- Who are Pathos's investors?
- Pathos's investors include Cota Capital.